Ismayil Ahmet
About Ismayil Ahmet
Ismayil Ahmet is a Staff Scientist leading a translational cardiovascular research group at the National Institute on Aging, NIH. He specializes in cardiovascular physiology and pharmacology, focusing on aging biomarkers and treatments for heart conditions.
Work at National Institutes of Health
Ismayil Ahmet has been a Staff Scientist at the National Institutes of Health (NIH) since 2008, contributing to the field of cardiovascular research for over 16 years. He leads a translational cardiovascular research group at the National Institute on Aging, focusing on the intersection of cardiovascular health and aging. Prior to his current role, he served as a Post-doctoral fellow from 2000 to 2005 and as a Research Fellow from 2005 to 2008, both in Bethesda, Maryland. His extensive experience at NIH has positioned him as a key figure in the study of cardiovascular physiology and related areas.
Education and Expertise
Ismayil Ahmet holds a Doctor of Philosophy degree from Osaka University, where he studied Medicine from 1995 to 2000. He also earned a Doctor of Medicine degree from Xi'an Medical University, completing his studies from 1988 to 1993. His educational background provides a strong foundation in medical science, particularly in cardiovascular physiology, pharmacology, pathology, imaging, and surgery. His expertise encompasses both large and small animal models, including transgenic models, which are essential for his research in cardiovascular diseases.
Research Focus and Areas
Ahmet's research primarily focuses on biomarkers of aging, mechanisms of reverse aging, and the treatment of hypertrophic cardiomyopathy and heart failure. He engages in drug discovery efforts aimed at addressing chronic heart failure and hypertension. Additionally, he is involved in biomarker discovery related to cardiovascular aging. His work aims to advance understanding and treatment options for age-related cardiovascular conditions, contributing valuable insights to the field.
Collaborative Opportunities
Ismayil Ahmet is open to scientific collaborations and consultations within the fields of cardiovascular diseases and aging. His willingness to engage with other researchers and institutions highlights his commitment to advancing knowledge and developing innovative solutions in cardiovascular health. This collaborative approach fosters an environment of shared expertise and resources, which is essential for tackling complex health challenges.